CD4 and myocardial infarction: Using a murine myocardial infarction (MI) model, the authors found that the administration of activated CD4+ T cell-derived sEV elicited a deterioration of cardiac function post-MI, which was dependent on miR-142-3p, a miRNA enriched in the plasma of heart transplant patients [84,85].